- Release Date: 18/12/12 18:05
- Summary: RELINT: FPH: Disclosure of Officers and Director relevant interests
- Price Sensitive: No
- Download Document 9.29KB
FPH 18/12/2012 16:05 RELINT REL: 1605 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Officers and Director relevant interests Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 75,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid from acqusition Not applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration paid from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 150,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid for acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration paid from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 Name of director or officer of public issuer: Michael Robert BATTY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Group Operations Manager B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 54,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial interest Name of registered holder of securities Michael Robert BATTY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid from acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration paid from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 150,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid from acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration received from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 110,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid from acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration received from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities 50,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not applicable Consideration paid from acquisition Not applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration received from lapse Not Applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 160,000 options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Michael Grenfell DANIELL D Details of acquisitions and disposals If the relevant interest was acquired-- Date of issue Not Applicable Consideration received from acquisition Not Applicable If the relevant interest was disposed of-- Date of lapse 17 December 2012 Consideration received from lapse Not applicable Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place Lapse of options to acquire ordinary shares on expiry date of the 2007 issue under the 2003 option plan E Total number of transactions this notice relates to One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer 3 September 2012 End CA:00231295 For:FPH Type:RELINT Time:2012-12-18 16:05:55
Ann: RELINT: FPH: Disclosure of Officers and Dire
Add to My Watchlist
What is My Watchlist?
